{"id":"W2914108875","doi":"10.1016/j.ctrv.2019.02.001","title":"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Dabrafenib; Vemurafenib; Trametinib; Dacarbazine; Oncology; Internal medicine; Ipilimumab; Melanoma; Hazard ratio; Nivolumab; Randomized controlled trial; Population; Progression-free survival; Metastatic melanoma; Cancer; Immunotherapy; Chemotherapy; Cancer research; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003122313,0.000961084,0.008394031,0.0001228438,0.00006594128,0.0000221521,0.0003921131,0.0004035479,0.0003386459],"category_scores_gemma":[0.00002468529,0.000562193,0.007305143,0.0006500993,0.00005311492,0.000004962422,0.00006007992,0.00007443108,0.00002404515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001247901,"about_ca_system_score_gemma":0.0003731134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000482295,"about_ca_topic_score_gemma":0.0001742609,"domain_scores_codex":[0.9965823,0.0004548106,0.001334199,0.001010527,0.0001224114,0.0004957506],"domain_scores_gemma":[0.9967757,0.00009370467,0.00152713,0.001365922,0.0001248172,0.0001126747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004055373,0.00009193529,0.0000111327,0.005827496,0.2195137,0.000001748268,0.0000239792,0.00005743715,0.00004057485,0.00003444337,0.001596502,0.7727605],"study_design_scores_gemma":[0.0003193717,0.0005678032,9.801831e-7,0.0004094432,0.3666663,0.000002029363,0.000001258407,0.000002014071,0.00008179974,0.000003726936,0.631636,0.0003092526],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001858539,0.9921441,0.0001340885,0.00001552247,0.0002095778,0.005985869,0.001170829,0.00001659037,0.0003048424],"genre_scores_gemma":[0.00001253137,0.9807097,0.0009432868,0.0000821744,0.0002057612,0.007026693,0.006518159,0.00009298576,0.004408656],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7724513,"threshold_uncertainty_score":0.999683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2066071400116449,"score_gpt":0.3974582458880378,"score_spread":0.1908511058763929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}